Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

In 2015, Bluestone led a small clinical trial to isolate and grow Tregs from diabetes patients and then reinfuse the cells ...

Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...

Scientists at University College London have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies, a breakthrough that could lead to ...

A new study has identified a promising drug target for a common chronic illness that could shield insulin-producing cells from a destructive 'identity crisis.' ...

Researchers have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies.

Details: This summit organized by Oppenheimer & Co. in partnership with the University of Miami Sylvester Cancer Center, focuses on oncology advancements, offering Medicenna a platform to discuss its ...

Sanofi raised its interest in AlphaMedix when it bought a 16% stake in Orano Med, a subsidiary of French nuclear fuel company ...

ATNM-400 is advancing as a first-in-class, multi-tumor Actinium-225 radiotherapy candidate with activity across prostate and lung cancers, two of the largest cancer indications globally New ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...

New research reveals that astrocytes — not neurons — are responsible for stabilizing emotional memories by re-engaging during recall.